Treatment of neuroblastoma stage 4 with 131 I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study

Author： Klingebiel T. Bader P. Bares R. Beck J. Hero B. Jurgens H. Lang P. Niethammer D. Rath B. Handgretinger R.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.9, 1998-08, pp. : 1398-1402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatment

By Sonneveld P. Segeren C.M.

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 9-18

Elsevier

Access to resources Recommend Favorite

Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

By Kasper Bernd

Supportive Care in Cancer, Vol. 12, Iss. 3, 2004-03 ,pp. : 205-207

Springer Publishing Company

Access to resources Recommend Favorite

Randomised Study of High-dose Epirubicin Versus High-dose Epirubicin-Cisplatin Chemotherapy for Advanced Soft Tissue Sarcoma

By Jelic S. Kovcin V. Milanovic N. Babovic N. Kreacic M. Ristovic Z. Vlajic M. Filipovic-Ljeskovic I.

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 220-225

Elsevier

Access to resources Recommend Favorite

High-Dose Chemotherapy in Ovarian Cancer: Still Waiting for the Right Study

By Donato M.L.

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 1-2

Academic Press

Access to resources Recommend Favorite

Influence of cisplatin and doxorubicin on 125 I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines - defect in papillary hypertonicity

By Meco D. Lasorella A. Riccardi A. Servidei T. Mastrangelo R. Riccardi R.

European Journal of Cancer, Vol. 35, Iss. 8, 1999-08 ,pp. : 1227-1234

Elsevier

Access to resources Recommend Favorite